Article Information
History
- September 27, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Erika Garner-Spitzer1,
- Angelika Wagner1,
- Michael Kundi2,
- Hannes Stockinger3,
- Anna Repic3,
- Anna-Margarita Schoetta3,
- Venugopal Gudipati3,
- Johannes B. Huppa3,
- Renate Kunert4,
- Patrick Mayrhofer4,
- Thomas R. Kreil5,
- Maria R. Farcet5,
- Eva Hoeltl6 and
- Ursula Wiedermann1,*
- 1Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
- 2Center for Public Health, Medical University of Vienna, Vienna, Austria
- 3Institute for Hygiene and Applied Immunology, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
- 4Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna
- 5Global Pathogen Safety, Baxter AG, a Takeda company, Vienna, Austria
- 6Health Center Erste Bank, Erste Bank, Vienna, Austria
- ↵*Correspondence: Univ. Prof. Ursula Wiedermann, MD, PhD, Institute of Specific Prophylaxis and Tropical Medicine, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, Vienna A-1090, Austria, Email: ursula.wiedermann{at}meduniwien.ac.at